SmellTaste

We bring you the latest updates from SmellTaste through a simple and fast subscription.

We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.

Unsubscribe at any time without hassle.

SmellTaste's title: Home - SmellTaste

Is this your feed? Claim it!

Publisher: Unclaimed!

Message frequency: 0.05 / day

Message History

Update on access to Dupilumab for eligible NHS England patients with chronic rhinosinusitis with nasal polyps (CRSwNP)5 days

NICE, the National Institute for Health and Care Excellence, mandated that Dupilumab be made available to eligible* NHS eligible patients with severe CRSwNP within 90 days of it being approved. That 90 days has now passed. The drug is being funded centrally by NHS England. This means that all hospitals across England should now be able to prescribe the drug to eligible patien...

Read full story

Scottish Medicines Consortium approves Dupilumab for eligible NHS Scotland patients with chronic rhinosinusitis with...5 days

The Scottish Medicines Consortium (Scotland’s equivalent of NICE) has approved Dupilumab for use in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP), providing they meet the same eligibility criteria as those approved by NICE for England.

This is an important step forward. At SmellTaste, we worked hard to ensure the voices of people living wi...

Read full story